On Monday, Novavax announced the beginning of its Phase 3 trial for its vaccine candidate, named NVX-CoV2373, in the U.S. and Mexico.
On Monday, Novavax announced the beginning of its Phase 3 trial for its vaccine candidate, named NVX-CoV2373, in the U.S. and Mexico.
Another vaccine candidate is taking a step forward. Novavax announced Monday it is starting a phase three trial for its vaccine..
Moderna has expanded its phase 2/3 Covid-19 vaccine trial to include adolescents between the ages of 12 and 18 to gauge its..